Data being presented showcases AbbVie's breadth and depth of research across a range of therapeutic modalities such as T-Cell Engagers, BCL-2 Inhibitors and Antibody-Drug Conjugates for a spectrum...

Syantra Inc., a leader in blood-based molecular diagnostics, is pleased to announce scientific and community engagement at the San Antonio Breast Cancer Symposium (SABCS) taking place December...

Manufacturing tech company brings factory orchestration to the global stage AKRON, Ohio and NEW YORK, Dec. 2, 2025 /PRNewswire/ -- Harmoni, a manufacturing technology company that has developed a...

Synchrony (NYSE: SYF) President and Chief Executive Officer, Brian D. Doubles, and Chief Financial Officer, Brian J. Wenzel, will participate in a fireside chat at the 2025 Goldman Sachs Financial...

MiniPRO™ - Independent Control of up to 24 Cultures for Scalable, Closed-System Cell Therapy Development CAMARILLO, Calif., Dec. 2, 2025 /PRNewswire/ -- PBS Biotech ("PBS"), a leader in...

Solu Therapeutics, a biotechnology company pioneering novel therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced that it will present...

Neusoft Medical Systems Co., Ltd. ("Neusoft Medical"), a global leader in medical imaging, is showcasing its comprehensive portfolio of intelligent healthcare innovations at the Radiological...

The third edition of Taiwan Design Week returns from 29 November to 7 December 2025, inviting global visitors to explore how design can shape a shared future. Organized by the Taiwan Design...

Alcott Global has officially announced the next edition of its flagship event, Makers & Movers, scheduled for April 22–23, 2026, at The Dolder Grand in Zürich. The event is set to convene more than

Etalanetug demonstrated reduction of eMTBR-tau243, a novel CSF and plasma biomarker that specifically reflects tau tangle pathology, in Phase Ib/II study TOKYO, Dec. 1, 2025 /PRNewswire/ -- Eisai...